0001181431-12-066889.txt : 20121221 0001181431-12-066889.hdr.sgml : 20121221 20121221182447 ACCESSION NUMBER: 0001181431-12-066889 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121219 FILED AS OF DATE: 20121221 DATE AS OF CHANGE: 20121221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Caballa Susan CENTRAL INDEX KEY: 0001489530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34703 FILM NUMBER: 121283159 MAIL ADDRESS: STREET 1: 6120 WINDWARD PARKWAY STREET 2: SUITE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALIMERA SCIENCES INC CENTRAL INDEX KEY: 0001267602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6120 WINDWARD PARKWAY STREET 2: STE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 6789905740 MAIL ADDRESS: STREET 1: 6120 WINDWARD PARKWAY STREET 2: STE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 rrd364460.xml FORM 4 X0306 4 2012-12-19 0 0001267602 ALIMERA SCIENCES INC ALIM 0001489530 Caballa Susan 6120 WINDWARD PARKWAY, SUITE 290 ALPHARETTA GA 30005 0 1 0 0 SVP,Regulatory&Medical Affairs Employee Stock Option (Right to Buy) 1.66 2012-12-19 4 A 0 90000 0 A 2022-12-18 Common Stock 90000 90000 D Employee Stock Option (Right to Buy) 1.66 2012-12-19 4 A 0 35000 0 A 2022-12-18 Common Stock 35000 35000 D This option shall vest in forty-eight equal monthly installments beginning on January 19, 2013, provided Reporting Person remains continuously employed by the Issuer through each vesting period. This option shall become exercisable if and only if on or before June 30, 2013 the United Kingdom's National Institute for Health and Clinical Excellence recommends ILUVIEN(R) for the treatment of diabetic macular edema, in which case this option shall vest in forty-eight equal monthly installments beginning on January 19, 2013, provided Reporting Person remains continuously employed by the Issuer through each vesting period. /s/ Susan Caballa 2012-12-20